A detailed history of Edgemoor Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Edgemoor Investment Advisors, Inc. holds 2,864 shares of ABT stock, worth $338,324. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,864
Previous 2,801 2.25%
Holding current value
$338,324
Previous $291,000 12.03%
% of portfolio
0.03%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $6,304 - $7,442
63 Added 2.25%
2,864 $326,000
Q2 2024

Aug 07, 2024

SELL
$100.73 - $112.44 $1,611 - $1,799
-16 Reduced 0.57%
2,801 $291,000
Q1 2024

May 09, 2024

BUY
$109.52 - $120.96 $19,385 - $21,409
177 Added 6.7%
2,817 $320,000
Q4 2023

Feb 07, 2024

BUY
$90.19 - $110.4 $90 - $110
1 Added 0.04%
2,640 $290,000
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $95 - $114
1 Added 0.04%
2,639 $255,000
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $100 - $112
1 Added 0.04%
2,638 $287,000
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $96 - $114
1 Added 0.04%
2,637 $267,000
Q4 2022

Feb 07, 2023

BUY
$95.06 - $111.52 $95 - $111
1 Added 0.04%
2,636 $289,000
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $37,059 - $42,907
-383 Reduced 12.69%
2,635 $255,000
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $102,682 - $124,110
-1,006 Reduced 25.0%
3,018 $328,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $17,217 - $20,995
151 Added 3.9%
4,024 $476,000
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $66,314 - $81,198
574 Added 17.4%
3,873 $545,000
Q3 2021

Nov 02, 2021

SELL
$116.66 - $129.06 $46,664 - $51,624
-400 Reduced 10.81%
3,299 $390,000
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $740 - $871
7 Added 0.19%
3,699 $429,000
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $3,918 - $4,616
36 Added 0.98%
3,692 $442,000
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $1,785 - $1,945
-17 Reduced 0.46%
3,656 $400,000
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $70,287 - $85,359
767 Added 26.39%
3,673 $400,000
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $1,531 - $1,960
20 Added 0.69%
2,906 $266,000
Q3 2019

Nov 06, 2019

SELL
$81.84 - $88.74 $7,774 - $8,430
-95 Reduced 3.19%
2,886 $241,000
Q3 2018

Oct 26, 2018

BUY
$60.81 - $73.36 $181,274 - $218,686
2,981 New
2,981 $219,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Edgemoor Investment Advisors, Inc. Portfolio

Follow Edgemoor Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgemoor Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Edgemoor Investment Advisors, Inc. with notifications on news.